General Information of the Compound
Compound ID
CP0110909
Compound Name
1-[[6-ethyl-1-[(4-fluorophenyl)methyl]-5-methyl-2-oxopyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid
    Show/Hide
Synonyms
S-777469
    Show/Hide
Structure
Formula
C23H27FN2O4
Molecular Weight
414.477
Canonical SMILES
CCc1c(C)cc(C(=O)NC2(CCCCC2)C(O)=O)c(=O)n1Cc1ccc(F)cc1
    Show/Hide
InChI
InChI=1S/C23H27FN2O4/c1-3-19-15(2)13-18(20(27)25-23(22(29)30)11-5-4-6-12-23)21(28)26(19)14-16-7-9-17(24)10-8-16/h7-10,13H,3-6,11-12,14H2,1-2H3,(H,25,27)(H,29,30)
    Show/Hide
InChIKey
JIYXOJFSPOFZPY-UHFFFAOYSA-N
CAS
885496-53-7
Physicochemical Property
logP
3.42382
Rotatable Bonds
6
Heavy Atom Count
30
Polar Areas
88.4
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 57331749
SID: 136334051
ChEMBL ID
CHEMBL2019090
DrugBank ID
DB16321
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01298, Cannabinoid receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 > 2000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 4067 nM
2 Ki = 4600 nM
3 Ki = 4607 nM
Protein ID: PT00834, Cannabinoid receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 24 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 36 nM
Clinical Information about the Compound
Drug 1 ( S-777469 )
Drug Name S-777469
Company Shionogi USA Inc
Indication
Atopic dermatitis
Phase 2
Target(s)
Cannabinoid receptor 2 (CB2)
Agonist